SHREE GANESH REMEDIES
Back to All Ratios
|
SHREE GANESH REMEDIES Last 5 Year EPS Growth History
[Consolidated]
Mar2024 | Mar2020 | Mar2019 | |
---|---|---|---|
EPS Growth(%) | 87.52 | 67.93 | - |
What is the latest EPS Growth ratio of SHREE GANESH REMEDIES ?
Year | EPS Growth |
---|---|
Mar2024 | 87.52 |
Mar2020 | 67.93 |
Mar2019 | - |
How is EPS Growth of SHREE GANESH REMEDIES Trending?
Years | EPS Growth | % Change | |
---|---|---|---|
Mar2024 | 87.52 | 28.84 | |
Mar2020 | 67.93 | 0 | |
Mar2019 | 0 | - |
Other Financial Ratios of SHREE GANESH REMEDIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EPS Growth ratio of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹902.8 Cr | 2.6% | -11.2% | 7.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 2.6% |
-11.2% |
7.5% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses